Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenli Dong

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2018
High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic CancerSarah A Bannon, Maria F Montiel, Jennifer B Goldstein, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) LymphomaPenny Fang, Jillian R Gunther, Chelsea C Pinnix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2018
Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast CancerPatricia A Parker, Susan K Peterson, Yu Shen, et al.
Plos One|February 18, 2010
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lungPing Yuan, Humam Kadara, Carmen Behrens, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville ScoreSarah A Milgrom, Wenli Dong, Mani Akhtari, et al.
Breast Cancer Research and Treatment|August 2, 2025
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective studyToshiaki Iwase, Nithya Sridhar, Megumi Kai, et al.
The Lancet Regional Health. Western Pacific|September 11, 2023
Anaesthesia-related mortality within 24 h following 9,391,669 anaesthetics in 10 cities in Hubei Province, China: a serial cross-sectional studyYu Wang, Jie Wang, Xihong Ye, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 2, 2013
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trialJason R Westin, Michael A Thompson, Vince D Cataldo, et al.
Blood|October 18, 2017
Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentationMani Akhtari, Sarah A Milgrom, Chelsea C Pinnix, et al.
British Journal of Haematology|August 24, 2017
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?Sarah A Milgrom, Chelsea C Pinnix, Hubert Chuang, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2018
High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic CancerSarah A Bannon, Maria F Montiel, Jennifer B Goldstein, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) LymphomaPenny Fang, Jillian R Gunther, Chelsea C Pinnix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2018
Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast CancerPatricia A Parker, Susan K Peterson, Yu Shen, et al.
Plos One|February 18, 2010
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lungPing Yuan, Humam Kadara, Carmen Behrens, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville ScoreSarah A Milgrom, Wenli Dong, Mani Akhtari, et al.
Breast Cancer Research and Treatment|August 2, 2025
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective studyToshiaki Iwase, Nithya Sridhar, Megumi Kai, et al.
The Lancet Regional Health. Western Pacific|September 11, 2023
Anaesthesia-related mortality within 24 h following 9,391,669 anaesthetics in 10 cities in Hubei Province, China: a serial cross-sectional studyYu Wang, Jie Wang, Xihong Ye, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 2, 2013
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trialJason R Westin, Michael A Thompson, Vince D Cataldo, et al.
Blood|October 18, 2017
Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentationMani Akhtari, Sarah A Milgrom, Chelsea C Pinnix, et al.
British Journal of Haematology|August 24, 2017
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?Sarah A Milgrom, Chelsea C Pinnix, Hubert Chuang, et al.
Pageof 8